6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
50m ago	$9 Trillion Is Pouring Into American Manufacturing — And It’s Just Getting Started
2h ago	Elektros Inc. Unveils Transformational Lithium Opportunity and Breakthrough EV Charging Patent at a Compelling Market Entry Point
4h ago	Dollar Tree Named Entitlement Sponsor for New England's Only NASCAR Cup Series Race
12h ago	Planet Launches Three Additional High-Resolution Pelican Satellites
15h ago	EgyptAir Takes Delivery of First Boeing 737 MAX Jet

About

Hemostemix Inc — investor relations, events, news, and company updates on 6ix.

Latest News

Hemostemix Leadership Attending Abundance360 Summit

Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Hemostemix Closes $480,000 Private Placement at $0.12 per Share

Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01

How Hemostemix Inc runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

Cardiac Study Breakthrough: Promising Early Phase Data

Cardiac Study Breakthrough: Promising Early Phase Data

Apr 25, 2026

Cardiovascular Ischemia: Hope When Standard Options Fail

Cardiovascular Ischemia: Hope When Standard Options Fail

Apr 24, 2026

Regenerative Medicine: Root Cause Cardiac Repair Explained

Regenerative Medicine: Root Cause Cardiac Repair Explained

Apr 23, 2026

Cardiovascular Ischemia: Why 'Managing It' Isn't Enough

Cardiovascular Ischemia: Why 'Managing It' Isn't Enough

Apr 22, 2026

Community Chat

Ask AI